Unknown

Dataset Information

0

MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6.


ABSTRACT: Increasing evidence has suggested that dysregulation of microRNAs (miRNAs) could contribute to human disease including cancer. Previous miRNA microarray analysis illustrated that miR-320c is down-regulated in various cancers. However, the roles of miR-320c in human bladder cancer have not been well elucidated. Therefore, this study was performed to investigate the biological functions and molecular mechanisms of miR-320c in human bladder cancer cell lines, discussing whether it could be a therapeutic biomarker of bladder cancer in the future.Two human bladder cancer cell lines and samples from thirteen patients with bladder cancer were analyzed for the expression of miR-320c by quantitative RT-PCR. Over-expression of miR-320c was established by transfecting mimics into T24 and UM-UC-3. Cell proliferation and cell cycle were assessed by cell viability assay, flow cytometry and colony formation assay. Cell motility ability was evaluated by transwell assay. The target gene of miR-320c was determined by luciferase assay, quantitative RT-PCR and western blot. The regulation of cell cycle and mobility by miR-320c was analyzed by western blot.We observed that miR-320c was down-regulated in human bladder cancer tissues and bladder cancer cell lines T24 and UM-UC-3. Over-expression of miR-320c could induce G1 phase arrest in UM-UC-3 and T24 cells, and subsequently inhibited cell growth. We also indentified miR-320c could impair UM-UC-3 and T24 cell motility. In addition, we identified CDK6, a cell cycle regulator, as a novel target of miR-320c. Moreover, we demonstrated miR-320c could induce bladder cancer cell cycle arrest and mobility via regulating CDK6. We also observed that inhibition of miR-320c or restoration of CDK6 in miR-320c-over-expressed bladder cancer cells partly reversed the suppressive effects of miR-320c.miR-320c could inhibit the proliferation, migration and invasion of bladder cancer cells via regulating CDK6. Our study revealed that miR-320c could be a therapeutic biomarker of bladder cancer in the future.

SUBMITTER: Wang X 

PROVIDER: S-EPMC4431489 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6.

Wang Xiao X   Wu Jian J   Lin Yiwei Y   Zhu Yi Y   Xu Xianglai X   Xu Xin X   Liang Zhen Z   Li Shiqi S   Hu Zhenghui Z   Zheng Xiangyi X   Xie Liping L  

Journal of experimental & clinical cancer research : CR 20140902


<h4>Background</h4>Increasing evidence has suggested that dysregulation of microRNAs (miRNAs) could contribute to human disease including cancer. Previous miRNA microarray analysis illustrated that miR-320c is down-regulated in various cancers. However, the roles of miR-320c in human bladder cancer have not been well elucidated. Therefore, this study was performed to investigate the biological functions and molecular mechanisms of miR-320c in human bladder cancer cell lines, discussing whether i  ...[more]

Similar Datasets

| S-EPMC8607341 | biostudies-literature
| S-EPMC9253122 | biostudies-literature
| S-EPMC10039829 | biostudies-literature
| S-EPMC5666665 | biostudies-literature
| S-EPMC7572640 | biostudies-literature
| S-EPMC7149478 | biostudies-literature
| S-EPMC4873751 | biostudies-literature
| S-EPMC4228407 | biostudies-literature
| S-EPMC8806593 | biostudies-literature
| S-EPMC5364079 | biostudies-literature